Jiahua Li

Jiahua Li

Nephrology

45 Francis Street
2nd Floor
Boston, MA 02115

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 19 publications

Toward a Treatment Goal Framework for Emerging Therapies in IgAN: Implications for Future Research.

Toward a Treatment Goal Framework for Emerging Therapies in IgAN: Implications for Future Research.

Journal: Kidney international reports

Published: August 30, 2026

Povetacicept for IgA Nephropathy and Primary Membranous Nephropathy.

Povetacicept for IgA Nephropathy and Primary Membranous Nephropathy.

Journal: Kidney international reports

Published: October 15, 2025

3D printed hemodialysis access and subcutaneous volume model as a guide for cannulation: A proof of concept training tool.

3D printed hemodialysis access and subcutaneous volume model as a guide for cannulation: A proof of concept training tool.

Journal: Seminars in dialysis

Published: August 27, 2022

Medication Optimization for New Initiators of Empagliflozin for Diabetic Kidney Disease.

Medication Optimization for New Initiators of Empagliflozin for Diabetic Kidney Disease.

Journal: Clinical diabetes : a publication of the American Diabetes Association

Published: June 07, 2022

Prescribing Patterns of Sodium-Glucose Cotransporter-2 Inhibitors in Patients with CKD: A Cross-Sectional Registry Analysis.

Prescribing Patterns of Sodium-Glucose Cotransporter-2 Inhibitors in Patients with CKD: A Cross-Sectional Registry Analysis.

Journal: Kidney360

Published: December 07, 2021

Addressing the nephrology workforce shortage via a novel undergraduate pipeline program: the Kidney Disease Screening and Awareness Program (KDSAP) at 10 years.

Addressing the nephrology workforce shortage via a novel undergraduate pipeline program: the Kidney Disease Screening and Awareness Program (KDSAP) at 10 years.

Journal: Kidney international

Published: August 03, 2021

Advancing American Kidney Health and the Role of Sodium-Glucose Cotransporter-2 Inhibitors: A Missed Opportunity.

Advancing American Kidney Health and the Role of Sodium-Glucose Cotransporter-2 Inhibitors: A Missed Opportunity.

Journal: Clinical journal of the American Society of Nephrology : CJASN

Published: June 17, 2021

Opioid Use in the Nondialysis Chronic Kidney Disease Population.

Opioid Use in the Nondialysis Chronic Kidney Disease Population.

Journal: Seminars in nephrology

Published: April 26, 2021

High detection rate and low efficacy in controlling high blood pressure (≥130/80 mmHg) in the community-based health screening: results from KDSAP.

High detection rate and low efficacy in controlling high blood pressure (≥130/80 mmHg) in the community-based health screening: results from KDSAP.

Journal: European journal of preventive cardiology

Published: July 07, 2020

Decision Algorithm for Prescribing SGLT2 Inhibitors and GLP-1 Receptor Agonists for Diabetic Kidney Disease.

Decision Algorithm for Prescribing SGLT2 Inhibitors and GLP-1 Receptor Agonists for Diabetic Kidney Disease.

Journal: Clinical journal of the American Society of Nephrology : CJASN

Published: June 11, 2020

KIM-1 mediates fatty acid uptake by renal tubular cells to promote progressive diabetic kidney disease.

KIM-1 mediates fatty acid uptake by renal tubular cells to promote progressive diabetic kidney disease.

Journal: Cell metabolism

Published: June 08, 2020

A Pilot Study Embedding Clinical Pharmacists Within an Interprofessional Nephrology Clinic for the Initiation and Monitoring of Empagliflozin in Diabetic Kidney Disease.

A Pilot Study Embedding Clinical Pharmacists Within an Interprofessional Nephrology Clinic for the Initiation and Monitoring of Empagliflozin in Diabetic Kidney Disease.

Journal: Journal of pharmacy practice

Published: September 26, 2019

Showing 1-12 of 19

Last Updated: 09/26/2026